Alpha Tau Medical to Spotlight Alpha DaRT at Healthcare Conference
Company Announcements

Alpha Tau Medical to Spotlight Alpha DaRT at Healthcare Conference

Alpha Tau Medical Ltd (DRTS) has released an update.

Alpha Tau Medical Ltd., a pioneer in alpha-radiation cancer therapy with its Alpha DaRT™ technology, has announced that CFO Raphi Levy will present at the Jefferies Global Healthcare Conference in New York on June 5th, 2024. The company, founded in 2016, specializes in a novel treatment aimed at solid tumors that minimizes damage to surrounding healthy tissues. Investors will have the opportunity for one-on-one meetings with Mr. Levy during the conference.

For further insights into DRTS stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskAlpha Tau Medical to Showcase Cancer Therapy at Global Conferences
GlobeNewswireAlpha Tau to Participate in the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference, and the Lytham Partners Fall 2024 Investor Conference
TheFlyAlpha Tau resumed with a Buy at Citi
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!